Category: Myelin Repair

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

August 10, 2026 07:00 ET  | Source: Quantum BioPharma Major Regulatory Milestone Positions Company to Initiate Randomized, Double-Blind, Placebo-Controlled Phase 2 Study…

Stuart Schlossman

New research findings challenge old beliefs about myelin repair in MS

Study reveals myelin-making cells are constantly being produced Written by Marisa Wexler, MS Oligodendrocytes, the cells responsible for making myelin, are constantly…

Stuart Schlossman

FDA OKs first human trial of oral MS remyelination therapy PTD802

New US study to evaluate treatment’s safety, tolerability in healthy volunteers Written by Michela Luciano, PhD | June 25, 2026 The U.S. Food…

Stuart Schlossman

Key multiple sclerosis models reveal different damage timelines, offering roadmap for myelin repair studies

May 18, 2026 – by University of Notre Dame – edited by Sadie Harley, reviewed by Robert Egan More than…

Stuart Schlossman

Brain sugar levels act as signal for myelin growth, study finds

Studies in mice, cells show link between glucose and oligodendrocytes Written by Marisa Wexler, MS | May 4, 2026 The amount of sugar…

Stuart Schlossman

Brain inflammation may help repair myelin, animal study shows

Findings could guide future repair-focused treatments for MS Written by Marisa Wexler, MS | April 28, 2026 Brain inflammation is…

Stuart Schlossman

Lucid-MS moves toward clinical trial in US that will enroll MS patients

Quantum names principal investigator, to soon seek FDA OK to launch study Written by Michela Luciano, PhD | March 30, 2026 Quantum Biopharma is…

Stuart Schlossman

Categories

Latest Blog Posts